Skip to content

Harrow HROW Free cash flow margin

Free cash flow margin at other companies

AbbVie logo
AbbVieABBV
31.8%+5.0pp
Bausch + Lomb logo
Bausch + LombBLCO
-3.4%0.0pp
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-463%+2,860pp
Viatris logo
ViatrisVTRS
12.3%-1.0pp
Bausch Health Companies logo
Bausch Health CompaniesBHC
9.8%-2.8pp
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
-28%-12.6pp

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Calculated from Harrow’s reported figures.

Based on trailing twelve months.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's free cash flow margin?
Harrow (HROW) reported free cash flow margin of 5.7% in Q1 2026.
How has Harrow's free cash flow margin changed year-over-year?
Harrow's free cash flow margin increased by 727.8% year-over-year, from -0.9% to 5.7%.
What is the long-term trend for Harrow's free cash flow margin?
Over 3 years (2022 to 2025), Harrow's free cash flow margin has grown at a 152.1% compound annual growth rate (CAGR), from -1% to 16.1%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.